Quidelortho (NASDAQ: QDEL) net income
Quidelortho reported a net loss of $1,132m for fiscal 2025; in fiscal 2024 it reported a net loss of $2,052m. Earnings per share were −$16.69.
Quidelortho's best year of the last 5 was fiscal 2021. The biggest drop was in fiscal 2022, −22.1%. It reported a loss in 3 of those 5 years.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Net income by fiscal year
| Fiscal year | Net income | Change | Net margin | Earnings per share |
|---|---|---|---|---|
| 2025 | −$1,132m | — | −41.5% | −$16.69 |
| 2024 | −$2,052m | — | −73.7% | −$30.54 |
| 2023 | −$10.1m | −101.8% | −0.3% | −$0.15 |
| 2022 | $548.7m | −22.1% | 16.8% | $9.66 |
| 2021 | $704.2m | — | 41.5% | $16.74 |
The change compares each fiscal year with the one before and is not calculated when the previous year closed with a loss. Net margin is net income over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Quidelortho net income compared with its sector
By net income for its latest fiscal year, Quidelortho ranks 495th of the 501 US health care companies with a page on Celsmar. The sector median net margin is −6.2%; that of Quidelortho, −41.5%.
| Rank | Company | Net income | Net margin |
|---|---|---|---|
| 493rd | Acadia Healthcare | −$1,103m | −33.3% |
| 494th | Revolution Medicines | −$1,131m | — |
| 495th | Quidelortho | −$1,132m | −41.5% |
| 496th | Enovis | −$1,184m | −52.7% |
| 497th | Insmed | −$1,277m | −210.5% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the net income of Quidelortho
- How much did Quidelortho earn in fiscal 2025?
- Quidelortho reported a net loss of $1,132m for fiscal 2025. In fiscal 2024 it reported a net loss of $2,052m.
- What are the earnings per share of Quidelortho?
- They were −$16.69 in fiscal 2025, compared with −$30.54 in fiscal 2024.
- What was the most profitable year for Quidelortho?
- Of its last 5 fiscal years, fiscal 2021, with $704.2m.
- Where does Quidelortho rank in its sector by net income?
- It ranks 495th of the 501 US health care companies with a page on Celsmar, by net income for its latest fiscal year.
- Where do the figures for Quidelortho come from?
- From the annual report (Form 10-K) that Quidelortho files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Quidelortho files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021. More on Quidelortho: the Quidelortho page · annual accounts · revenue · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.